Jun 07, 2023 / 05:00PM GMT
Andrew Tsai - Jefferies LLC - Analyst
Hi, everyone. We're going to get started on our next session. I'm Andrew Tsai, senior biotech analyst here at Jefferies. And it's my pleasure to have Supernus joining us today. I have Jack Khattar, CEO. So welcome, Jack.
Jack Khattar - Supernus Pharmaceuticals, Inc. - President & CEO
Thank you. Thanks for having me.
Andrew Tsai - Jefferies LLC - Analyst
Jack, so for those in the audience who might be less familiar with Supernus, maybe give us a background about the company. Any opening remarks you'd like to make and then we can talk about catalysts to look forward to potentially in the next six or four months.
Jack Khattar - Supernus Pharmaceuticals, Inc. - President & CEO
Again, good afternoon, everyone. And thanks for coming here. Just a quick reminder, I will be making forward-looking statements, so please check the risk factors associated with the business in our SEC filings.
So as a very brief background for those
Supernus Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers